VAKONDA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 56,656 | 14,255 | 107,199 | 199,815 | 174,185 | 155,622 | 142,662 | 232,218 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -31,769 | -10,695 | 20,490 | 5,195 | -38,196 | 2,650 | -30,745 | -86,117 |
| Equity | 192,022 | 187,457 | 207,947 | -75,276 | -111,697 | -109,047 | -139,792 | -225,909 |
| Liabilities | 79,254 | 90,346 | 144,133 | 239,734 | 260,905 | 266,018 | 238,877 | 266,782 |
| Non-current assets | 65,636 | 64,350 | 84,389 | 80,316 | 73,617 | 73,617 | 73,617 | 13,826 |
| Current assets | 205,640 | 212,926 | 267,390 | 83,621 | 75,031 | 82,964 | 24,858 | 26,747 |
| Total assets | 271,276 | 277,276 | 351,779 | 163,937 | 148,648 | 156,581 | 98,475 | 40,573 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 9,835 | 15,868 | 28,123 |
| Social insurance contributions | - | - | - | - | - | 6,221 | 14,072 | 23,009 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -67.4% | -74.8% | +652.0% | +86.4% | -12.8% | -10.7% | -8.3% | +62.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -11.7% | -3.9% | 5.8% | 3.2% | -25.7% | 1.7% | -31.2% | -212.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -16.5% | -5.7% | 9.9% | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -56.1% | -75.0% | 19.1% | 2.6% | -21.9% | 1.7% | -21.6% | -37.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 0.5 | 0.7 | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 16,997 | 7,128 | 53,600 | 59,945 | 43,546 | 38,112 | 28,532 | 48,888 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
VAKONDA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-05-04 | 2025-05-05 | 9.12 |
| 2025-04-16 | 2025-05-01 | 9.12 |
| 2023-05-16 | 2023-05-17 | 604.71 |
VAKONDA - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-09-26 | 2025-10-18 | 3.42 |
| 2025-09-25 | 2025-09-25 | 6.42 |
| 2025-08-28 | 2025-09-24 | 0.22 |
| 2025-08-19 | 2025-08-19 | 1198.18 |
| 2025-07-30 | 2025-07-31 | 1468.99 |
| 2025-07-29 | 2025-07-29 | 1468.59 |
| 2025-07-28 | 2025-07-28 | 1467.39 |
| 2025-07-25 | 2025-07-27 | 3.39 |
| 2025-07-16 | 2025-07-20 | 4.77 |
| 2025-06-28 | 2025-07-20 | 5.76 |
| 2025-06-22 | 2025-06-23 | 5.76 |
| 2025-06-17 | 2025-06-20 | 1167.69 |
| 2025-06-02 | 2025-06-05 | 7.31 |
| 2025-05-31 | 2025-06-01 | 6.01 |
| 2025-05-28 | 2025-05-30 | 1.37 |
| 2025-05-24 | 2025-05-27 | 170.37 |
| 2025-05-19 | 2025-05-23 | 1.37 |
| 2025-02-28 | 2025-03-24 | 0.01 |
| 2025-02-20 | 2025-02-24 | 36.68 |
| 2025-01-11 | 2025-01-13 | 10.06 |
| 2025-01-09 | 2025-01-10 | 975.21 |
| 2024-12-15 | 2024-12-16 | 893.47 |
| 2024-12-14 | 2024-12-14 | 890.35 |
| 2024-12-12 | 2024-12-13 | 886.75 |
| 2024-11-13 | 2024-11-23 | 508.51 |
| 2024-10-16 | 2024-10-16 | 5.1 |
| 2024-10-10 | 2024-10-15 | 729.21 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
VAKONDA, UAB is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €232.2K, up 62.8% year on year and 49.2% compared with two years earlier. Despite stronger sales, profitability weakened sharply: net loss reached €86.1K in 2025, after a loss of €30.7K in 2024 and a small profit of €2.6K in 2023. The 2025 profit margin was -37.1%. The balance sheet remained under pressure, with total assets of €40.6K, equity of -€225.9K and liabilities of €266.8K at year-end 2025. Long-term assets amounted to €13.8K and short-term assets to €26.7K. Asset turnover was 5.72x, indicating a relatively high use of the asset base to support revenue. Revenue per employee was €58.1K, while profit per employee was -€21.5K. Given the negative equity position, return ratios should be interpreted cautiously.